Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-23

FDA Approved: LUMIFY REDNESS RELIEVER EYE DROPS — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved a supplemental application for Lumify redness reliever eye drops (brimonidine tartrate) from Bausch & Lomb Incorporated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUMIFY REDNESS RELIEVER EYE DROPS (Brimonidine tartrate)

Snippet

SUPPL AP for LUMIFY REDNESS RELIEVER EYE DROPS (BRIMONIDINE TARTRATE)